Wolverine Trading, LLC Atea Pharmaceuticals, Inc. Call Options Transaction History

Wolverine Trading, LLC

  • $93.9 Billion
  • Q3 2024

Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q4 2022

Feb 14, 2023
BUY
$4.35 - $6.17 $90,479 - $128,336
20,800 New
20,800 $100,000
Q2 2022

Aug 15, 2022
SELL
$5.33 - $8.18 $151,905 - $233,130
-28,500 Closed
0 $0
Q1 2022

May 16, 2022
SELL
$5.5 - $9.19 $94,600 - $158,068
-17,200 Reduced 37.64%
28,500 $202,000
Q4 2021

Feb 14, 2022
BUY
$7.67 - $44.59 $350,519 - $2.04 Million
45,700 New
45,700 $414,000

Others Institutions Holding AVIR

# of Institutions
112
Shares Held
52.4M
Call Options Held
900
Put Options Held
126K
View Full List

About Atea Pharmaceuticals, Inc.

AVIR Quotes by TradingView
  • Ticker AVIR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 83,258,600
  • Market Cap $275M
  • Description
  • Atea Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focused on discovering, developing, and commercializing antiviral therapeutics for patients suffering from viral infections. Its lead product candidate is AT-527, an antiviral drug candidate that is in Phase II clinical trial for the treatment of patients with COVID-19. The ...
More about AVIR
Track This Portfolio

Track Wolverine Trading, LLC Portfolio

Follow Wolverine Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Trading, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email